Company performance
Add to research
Current Price
as of Jun 18, 2025$37.01
P/E Ratio
N/A
Market Cap
$5.89B
Description
Add to research
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.
Metrics
Add to research
Overview
- HQCarlsbad, CA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerIONS
- Price$37.01+2.38%
Trading Information
- Market cap$5.89B
- Float97.56%
- Average Daily Volume (1m)1,623,068
- Average Daily Volume (3m)1,677,843
- EPS-$2.98
Company
- Revenue$717.68M
- Rev growth (1yr)10.14%
- Net income-$146.94M
- Gross margin94.79%
- EBITDA margin-107.48%
- EBITDA-$141.46M
- EV$4.60B
- EV/Revenue6.41
- P/EN/A
- P/S8.19
- P/B12.37
- Debt/Equity411.63
Documents
Add to research
SEC Filings
Earnings Calls
Factset Street Account